CVS HEALTH Corp last reported quarterly results on Nov 4, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $108.4 billion (+5.4% year over year) and diluted EPS of $1.68. It usually reports 35–41 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 9, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Tuesday. Based on last year's release for the same quarter on Feb 10, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 35–41 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 4, 2026
35 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
108,399
+5.4%
|
2,172
+154.6%
|
1.68
+153.7%
|
|
Aug 5, 2026
36 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
106,096
+7.3%
|
2,979
+191.8%
|
2.31
+188.8%
|
|
May 6, 2026
36 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
100,426
+6.2%
|
2,943
+65.4%
|
2.30
+63.1%
|
|
Feb 10, 2026
41 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
105,693
+8.2%
|
2,943
+79.0%
|
2.29
+75.7%
|
|
Oct 29, 2025
29 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
102,871
+7.8%
|
-3,975
-4669.0%
|
-3.13
-4571.4%
|
|
Jul 31, 2025
31 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
98,915
+8.4%
|
1,021
-42.3%
|
0.80
-43.3%
|
|
May 1, 2025
31 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
94,588
+7.0%
|
1,779
+59.8%
|
1.41
+60.2%
|
|
Feb 12, 2025
43 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
97,710
+4.2%
|
1,644
-19.6%
|
1.30
-17.7%
|
Company profile
- Industry
- Retail-Drug Stores and Proprietary Stores (SIC 5912)
- Listed as
- CVS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Woonsocket, RI
- SEC filer status
- Large accelerated filer
- SEC CIK
- 64803
- Former names
- CVS CAREMARK CORP (until Sep 3, 2014); CVS/CAREMARK CORP (until May 8, 2007); CVS CORP (until Mar 22, 2007); MELVILLE CORP (until Jan 10, 1997)
Other Retail-Drug Stores and Proprietary Stores companies
- Guardian Pharmacy Services, Inc. GRDN
- 111, Inc. YI
- Petmed Express Inc PETS
- Ridgetech Inc. RDGT
- TREES Corp (Colorado) CANN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.